SENS PubMed Publication Search
Epigenetic quantification of immunosenescent CD8 + TEMRA cells in human blood
Aging Cell. 2022 Apr 9;e13607. doi: 10.1111/acel.13607.
Ahto Salumets 1 2, Liina Tserel 1, Anna P Rumm 1, Lehte Türk 1, Külli Kingo 3 4, Kai Saks 5, Astrid Oras 6, Raivo Uibo 6, Riin Tamm 7, Hedi Peterson 2, Kai Kisand 1, Pärt Peterson 1
Abstract:
...terminally differentiated CD8+ effector memory CD45RA+ TEMRA cells and their subsets have characteristics of cellular senescence, accumulate in older individuals, and are increased in age-related chronic inflammatory diseases. In a detailed T-cell profiling among individuals over 65 years of age, we found a high interindividual variation among CD8+ TEMRA populations. CD8+ TEMRA proportions correlated positively with cytomegalovirus (CMV) antibody levels, however, not with the chronological age. In the analysis of over 90 inflammation proteins, we identified plasma TRANCE/RANKL levels to associate with several differentiated T-cell populations, including CD8+ TEMRA and its CD28- subsets. Given the strong potential of CD8+ TEMRA cells as a biomarker for immunosenescence, we used deep-amplicon bisulfite sequencing to match their frequencies in flow cytometry with CpG site methylation levels and developed a computational model to predict CD8+ TEMRA cell proportions from whole blood genomic DNA. Our findings confirm the association of CD8+ TEMRA and its subsets with CMV infection and provide a novel tool for their high throughput epigenetic quantification as a biomarker of immunosenescence.
PMID: 35397197
Free Full-Text: https://onlinelibrary.wiley.com/doi/10.1111/acel.13607